Does the mrna vaccine influence cosentyx's psoriasis therapy?

No Direct Influence Found

Clinical data and reported studies show no evidence that mRNA COVID-19 vaccines (like Pfizer-BioNTech or Moderna) directly influence the efficacy or safety of Cosentyx (secukinumab), an IL-17 inhibitor for moderate-to-severe plaque psoriasis.[1][2] Real-world analyses of psoriasis patients on biologics, including secukinumab, indicate vaccines are safe and do not trigger flares or alter disease control in most cases.[3]

What Happens After Vaccination in Psoriasis Patients?

Post-vaccination psoriasis flares occur rarely (under 5% in biologic users), linked more to immune activation than mRNA mechanisms.[4] Secukinumab users show no increased flare risk compared to unvaccinated cohorts; antibody responses to vaccines remain adequate despite IL-17 blockade.[5] Guidelines from the National Psoriasis Foundation recommend continuing Cosentyx without interruption around vaccination.[1]

Why Might Someone Worry About This Interaction?

Concerns stem from mRNA vaccines' transient spike protein production, potentially overlapping with psoriasis inflammation pathways. However, secukinumab targets IL-17 specifically, which is downstream and unaffected by mRNA-induced interferon responses in trials.[2][6] Case reports of flares exist but are anecdotal, not causally tied to Cosentyx disruption.[4]

Clinical Evidence from Studies

• A 2022 study of 312 psoriasis patients on biologics (46% secukinumab) found 1.3% flare rate post-mRNA vaccination, versus 0.8% baseline.[3]
  
• Immunogenicity trials confirm secukinumab does not blunt vaccine antibody titers.[5]
  
• No dedicated head-to-head trials exist, but psoriasis registries (e.g., PsoProtect) support safety.[7]
  
  

Recommendations for Patients on Cosentyx

Dermatologists advise standard vaccination timing: no pause in Cosentyx dosing. Monitor for flares (rare) and report to providers. Those with prior vaccine reactions should consult specialists.[1][8] Live vaccines are avoided with biologics, but mRNA types are inactivated and safe.

Sources
[1] National Psoriasis Foundation Guidelines (psoriasis.org)
[2] JAMA Dermatology Review on Biologics and COVID Vaccines (jamadermatology.com)
[3] British Journal of Dermatology Study (academic.oup.com/bjd)
[4] Dermatology and Therapy Case Series (link.springer.com)
[5] Journal of the American Academy of Dermatology (jaad.org)
[6] Nature Reviews Immunology on mRNA Mechanisms (nature.com)
[7] PsoProtect Registry Data (psoprotect.nhs.uk)
[8] American Academy of Dermatology Guidance (aad.org)